Funded RFAs
Fiscal Year: 2023
This page provides detailed information about currently funded RFA initiatives both led by DCCPS/NCI, and those led by other NIH Institutes and Centers (I/Cs). Each initiative includes a table of funded grants.
You can click here to view the RFAs that are no longer active.
| Name (Click to view funded grants in the initiative) |
Initiative | Institution | Initiative Grantlist URL |
|---|---|---|---|
| Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3 Clinical Trial Required) | CA19-018 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2384&fy=2023 |
| Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3) | CA17-038 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2317&fy=2023 |
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | CA19-040 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2432&fy=2023 |
| Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed) | CA19-054 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2435&fy=2023 |
| Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed) | CA20-043 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2473&fy=2023 |
| Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) | CA21-030 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2706&fy=2023 |
| Centers on Telehealth Research for Cancer-Related Care (P50 Clinical Trial Required) | CA21-029 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2693&fy=2023 |
| Communication and Decision Making for Individuals with Inherited Cancer Syndromes (U01 Clinical Trial Optional) | CA20-006 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2408&fy=2023 |
| Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed) | CA21-032 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2684&fy=2023 |
| Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24) | CA16-017 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2277&fy=2023 |
| Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed) | CA21-022 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2708&fy=2023 |
| Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) | CA21-013 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2705&fy=2023 |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | CA21-014 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2686&fy=2023 |
| Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional) | OD21-009 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2700&fy=2023 |
| Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) | CA20-039 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2416&fy=2023 |
| Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) | CA20-038 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2439&fy=2023 |
| Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required) | CA21-031 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2682&fy=2023 |
| Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed) | RM21-011 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2696&fy=2023 |
| HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) | AI19-041 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2407&fy=2023 |
| Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research (Collaborative U01 Clinical Trial Optional) | TW21-001 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2678&fy=2023 |
| Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research Training (Collaborative U2R Clinical Trial Optional) | TW21-002 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2703&fy=2023 |
| Human Health Exposure Analysis Resource: Targeted Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed) | ES18-011 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2460&fy=2023 |
| Implementation Science for Cancer Control: Advanced Centers (P50 Clinical Trial Optional) | CA19-006 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2390&fy=2023 |
| Implementation Science for Cancer Control: Developing Centers (P50 Clinical Trial Optional) | CA19-005 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2391&fy=2023 |
| Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required) | CA19-033 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2392&fy=2023 |
| Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional) | CA20-035 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2483&fy=2023 |
| Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional) | CA18-027 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2393&fy=2023 |
| Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required) | CA18-026 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2385&fy=2023 |
| Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required) | CA19-064 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2464&fy=2023 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) | CA20-019 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2451&fy=2023 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) | CA21-003 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2683&fy=2023 |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) | CA20-017 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2450&fy=2023 |
| Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional) | DA21-009 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2453&fy=2023 |
| Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01, Clinical Trial Optional) | HG20-048 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2672&fy=2023 |
| Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Coordinating Center (U24 Clinical Trial Not Allowed) | DA20-004 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2434&fy=2023 |
| Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Data Analysis, Informatics and Resource Center (U24 Clinical Trial Not Allowed) | DA20-003 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2428&fy=2023 |
| Limited Competition: NIH Health Care Systems Research Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed) | AT22-002 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2690&fy=2023 |
| Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional) | CA21-021 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2699&fy=2023 |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) | CA19-029 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2479&fy=2023 |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Not Allowed) | CA20-014 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2688&fy=2023 |
| NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required) | CA20-015 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2681&fy=2023 |
| New Cohorts for Environmental Exposures and Cancer Risk (CEECR) Coordinating Center (U24 Clinical Trial Not Allowed) | CA20-050 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2692&fy=2023 |
| New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed) | CA20-049 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2488&fy=2023 |
| Nutrition for Precision Health, powered by the All of Us Research Program: Dietary Assessment Center (U24 Clinical Trial Optional) | RM21-004 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2704&fy=2023 |
| Nutrition for Precision Health, powered by the All of Us Research Program: Metabolomics and Clinical Assays Center (U24 Clinical Trial Not Allowed) | RM21-002 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2691&fy=2023 |
| Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care (R01 Clinical Trial Required) | CA19-035 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2409&fy=2023 |
| Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed) | CA19-046 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2441&fy=2023 |
| Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional) | CA19-045 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2414&fy=2023 |
| Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required) | OD20-010 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2671&fy=2023 |
| Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required) | OD18-008 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2499&fy=2023 |
| Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry Centers (U01 Clinical Trial Not Allowed) | HG20-001 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2490&fy=2023 |
| Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional) | CA18-019 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2378&fy=2023 |
| Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional) | CA20-004 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2459&fy=2023 |
| Research Centers for Population-based Research to Optimize Cancer Screening (PROSPR) Initiative (UM1) | CA16-016 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2276&fy=2023 |
| Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional) | CA20-027 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2491&fy=2023 |
| Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional) | CA20-028 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2455&fy=2023 |
| Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) | OD21-003 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2702&fy=2023 |
| Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required) | CA20-051 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2685&fy=2023 |
| Tobacco Regulatory Science (R01 Clinical Trial Optional) | OD19-028 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2446&fy=2023 |
| Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trial Not Allowed) | RM20-001 | Trans-NIH | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2445&fy=2023 |
| Utilizing Cohort Studies to Address Health Outcomes in Cancer Survivors (UG3/UH3 Clinical Trial Not Allowed) | CA20-030 | NCI | https://maps.cancer.gov/overview/map/initiative/grantlist.jsp?initiativeType=RFA&initiativeId=2457&fy=2023 |